Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The Brief Psychiatric Rating Scale for Children.

Literature DB >> 7111598

The Brief Psychiatric Rating Scale for Children.

J E Overall, B Pfefferbaum.

Abstract

Entities: Species

Mesh：

Year: 1982 PMID： 7111598

Source DB: PubMed Journal: Psychopharmacol Bull ISSN： 0048-5764

Keyword Cloud
Cited

× No keyword cloud information.

17 in total

1. Using a Brief Parent-Report Measure to Track Outcomes for Children and Teens with ADHD.

Authors: Alyssa McCarthy; Sunna Asghar; Timothy Wilens; Stephanie Romo; Hayley Kamin; Michael Jellinek; Michael Murphy
Journal: Child Psychiatry Hum Dev Date: 2016-06

2. New paradigms for treatment development.

Authors: Ellen L Stover; Linda Brady; Stephen R Marder
Journal: Schizophr Bull Date: 2007-08-02 Impact factor: 9.306

3. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.

Authors: B S Fernandes; J Steiner; M Berk; M L Molendijk; A Gonzalez-Pinto; C W Turck; P Nardin; C-A Gonçalves
Journal: Mol Psychiatry Date: 2014-09-30 Impact factor: 15.992

4. Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.

Authors: Marie Stentebjerg-Olesen; Stephen J Ganocy; Robert L Findling; Kiki Chang; Melissa P DelBello; John M Kane; Mauricio Tohen; Pia Jeppesen; Christoph U Correll
Journal: Eur Child Adolesc Psychiatry Date: 2015-06-02 Impact factor: 4.785

10. Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients.

Authors: Ann E Maloney; Linmarie Sikich
Journal: Neuropsychiatr Dis Treat Date: 2010-11-10 Impact factor: 2.570

The Brief Psychiatric Rating Scale for Children.

1. Using a Brief Parent-Report Measure to Track Outcomes for Children and Teens with ADHD.

2. New paradigms for treatment development.

3. Peripheral brain-derived neurotrophic factor in schizophrenia and the role of antipsychotics: meta-analysis and implications.

4. Early response or nonresponse at week 2 and week 3 predict ultimate response or nonresponse in adolescents with schizophrenia treated with olanzapine: results from a 6-week randomized, placebo-controlled trial.

5. Associations among obesity, acute weight gain, and response to treatment with olanzapine in adolescent schizophrenia.

6. Measuring treatment outcome and client satisfaction among children and families.

7. Play interactions and interviews of depressed and conduct disorder children and their mothers.

8. Tolerability of transcranial direct current stimulation in childhood-onset schizophrenia.

9. Brain volumes in psychotic youth with schizophrenia and mood disorders.

10. Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients.